BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33692205)

  • 1. Oncolytic Foamy Virus - generation and properties of a nonpathogenic replicating retroviral vector system that targets chronically proliferating cancer cells.
    Budzik KM; Nace RA; Ikeda Y; Russell SJ
    J Virol; 2021 Apr; 95(10):. PubMed ID: 33692205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the stability and intratumoral delivery of foreign transgenes encoded by an oncolytic Foamy Virus vector.
    Budzik KM; Nace RA; Ikeda Y; Russell SJ
    Cancer Gene Ther; 2022 Aug; 29(8-9):1240-1251. PubMed ID: 35145270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.
    Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T
    Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma.
    Abdullahi S; Jäkel M; Behrend SJ; Steiger K; Topping G; Krabbe T; Colombo A; Sandig V; Schiergens TS; Thasler WE; Werner J; Lichtenthaler SF; Schmid RM; Ebert O; Altomonte J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells.
    Lei J; Jacobus EJ; Taverner WK; Fisher KD; Hemmi S; West K; Slater L; Lilley F; Brown A; Champion B; Duffy MR; Seymour LW
    J Immunother Cancer; 2018 Jun; 6(1):55. PubMed ID: 29898782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching a replication-defective adenoviral vector into a replication-competent, oncolytic adenovirus.
    Nakashima H; Chiocca EA
    J Virol; 2014 Jan; 88(1):345-53. PubMed ID: 24155386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replication-competent foamy virus vectors.
    Heinkelein M; Hoffmann U; Lücke M; Imrich H; Müller JG; Meixensberger J; Westphahl M; Kretschmer A; Rethwilm A
    Cancer Gene Ther; 2005 Dec; 12(12):947-53. PubMed ID: 15905857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and prediction of the HIV-1 central polypurine tract influence on foamy viral vectors to transduce dividing and growth-arrested cells.
    Shityakov S; Förster C; Rethwilm A; Dandekar T
    ScientificWorldJournal; 2014; 2014():487969. PubMed ID: 25009830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus.
    Lo YT; Tian T; Nadeau PE; Park J; Mergia A
    J Virol; 2010 Mar; 84(6):2832-42. PubMed ID: 20032182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SGK1, a Serine/Threonine Kinase, Inhibits Prototype Foamy Virus Replication.
    Zhang J; Han C; Xiong Z; Qiu M; Tuo X; Wang C; Qiao W; Tan J
    Microbiol Spectr; 2022 Jun; 10(3):e0199521. PubMed ID: 35438526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
    Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
    J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.
    Dalba C; Klatzmann D; Logg CR; Kasahara N
    Curr Gene Ther; 2005 Dec; 5(6):655-67. PubMed ID: 16457654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.
    Finger C; Sun Y; Sanz L; Alvarez-Vallina L; Buchholz CJ; Cichutek K
    Cancer Gene Ther; 2005 May; 12(5):464-74. PubMed ID: 15692609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
    Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
    J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
    Liu TC; Zhang T; Fukuhara H; Kuroda T; Todo T; Canron X; Bikfalvi A; Martuza RL; Kurtz A; Rabkin SD
    Clin Cancer Res; 2006 Nov; 12(22):6791-9. PubMed ID: 17121900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmoviruses: nonviral/viral vectors for gene therapy.
    Noguiez-Hellin P; Meur MR; Salzmann JL; Klatzmann D
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4175-80. PubMed ID: 8633036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication competent Semliki Forest virus prolongs survival in experimental lung cancer.
    Määttä AM; Mäkinen K; Ketola A; Liimatainen T; Yongabi FN; Vähä-Koskela M; Pirinen R; Rautsi O; Pellinen R; Hinkkanen A; Wahlfors J
    Int J Cancer; 2008 Oct; 123(7):1704-11. PubMed ID: 18651570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.